Submission Details
| 510(k) Number | K033079 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 29, 2003 |
| Decision Date | November 26, 2003 |
| Days to Decision | 58 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K033079 is an FDA 510(k) clearance for the CHLAMYDIA IGG ELISA TEST SYSTEM, a Enzyme Linked Immunoabsorbent Assay, (chlamydiae Group) (Class I — General Controls, product code LJC), submitted by Trinity Biotech USA (Jamestown, US). The FDA issued a Cleared decision on November 26, 2003, 58 days after receiving the submission on September 29, 2003. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3120.
| 510(k) Number | K033079 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 29, 2003 |
| Decision Date | November 26, 2003 |
| Days to Decision | 58 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | LJC — Enzyme Linked Immunoabsorbent Assay, (chlamydiae Group) |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 866.3120 |